Leon Cooperman (Trades, Portfolio) is the founder and chairman of Omega Advisors, a hedge fund with approximately $6 billion under management. Mr. Cooperman was the CEO and Chairman of Goldman Sachs Asset Management. He worked at Goldman Sachs for 25 years. In 1991, he left Goldman and started Omega Advisors. He was a graduate of Columbia Business School, joined Goldman at the age of 24. In 1991, Mr. Cooper founded Omega Advisors with $450 million in capital.
According to GuruFocus , the Hedge Fund has 92 stocks on its portfolio, with a total value of $6794 Mil.
United Continental Holdings Inc (UAL)
The Company transports people and cargo through its mainline operations, which use jet aircraft with at least 118 seats, and its regional operations.
UAL returned a +58% since last trades of September 2014 when the Hedge Fund added 50,73% reaching a total of 2,626,874 shares with a total impact of 0,61% on its portfolio
On the last 12 months the stock performed a +60%
The Revenue of UAL grew of just 1% on the last 5 years, but with no debts and with positive returns such as a ROE of 46% and a ROC of 15%
Other Gurus holding large number of shares of UAL :
PRIMECAP Management reached a total of 18,536,173 shares with a total Impact of 0,24% on his portfolio
David Tepper reached a total of 4,956,901 shares with a total Impact of 0,3% on his portfoliolio.
Bluebird Bio Inc. (BLUE)
The Company is a clinical-stage biotechnology focused on transforming the lives of patients with severe genetic and orphan diseases using gene therapy products.
BLUE returned a +177% since last trades of September 2014 when Omega Advisors bought 38,600 shares with a total impact of 0,02% on its portfolio
On the last 12 months the price rose +344%
Other gurus that traded BLUE on past months
Steven Cohen reached a total of 594,900 shares with a total Impact of 0,03% on his portfolio
RS Investment Management reached a total of 301,800 shares with a total Impact of 0,04% on its portfoliolio.
AVANIR Pharmaceuticals (AVNR)
AVNR is a biopharmaceutical company focused on acquiring, developing and commercializing novel therapeutic products for the treatment of central nervous system disorders
AVNR returned a +151% since last trades of September 2014 when the hedge fund bought 100,000 shares with impact of 0,02% on its portfolio
During the last 5 years the company grew its revenue of 124,80% along with a 17,40% on its Book Value (per share)
Other gurus that heavily bought AVNR on past months
Paul Tudor Jones bought 127,470 shares with an Impact of 0,02% on his portfolio
Chuck Royce bought 1,289,100 shares with an Impact of 0,05% on his portfolio.
Actavis PLC (ACT)
ACT is a integrated specialty pharmaceutical company engaged in development, manufacturing, marketing, sale and distribution of generic, branded generic, brand name, biosimilar and over-the-counter pharmaceutical products
ACT returned a +22% since last trades of September 2014 when the hedge fund added 13,96% reaching a total of 706,472 shares with impact of 0,31% on its portfolio
During the last 5 years this company grew its revenue of 26.30% along with a + 19.40% on Free Cash Flow and + 19,10% on Book Value
Other gurus that heavily bought ACT on past months
Larry Robbins bought 1,717,858 shares with an Impact of 2,2% on his portfolio
Andreas Halvorsen added 111,15% with an Impact of 1,32% on his portfolio reaching a total of 2,550,336 shares
Daniel Loeb added 15% with an impact of 1,04% on his portfolio reaching a total of 2,875,000 shares
